Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




AI Sketch-Based Object Detection Tool Could Revolutionize Tumor Detection

By HospiMedica International staff writers
Posted on 23 Jun 2023

An artist's sketch is brimming with individual cues that words simply cannot express fully, reminding one of the old adage 'a picture is worth a thousand words'. More...

While emerging artificial intelligence (AI) systems can create images based on basic descriptive words, they often fail to express the unique artistic expression or specific match required by the user. Now, a novel sketch-based tool enables artists to guide the AI through sketches, enabling it to locate the precise object while ignoring irrelevant ones. This could be particularly beneficial in medical scenarios, such as identifying aggressive tumors.

Researchers at the University of Surrey (Surrey, UK) have developed an innovative sketch-based object detection tool. This unique tool enables users to sketch an object, which the AI then uses as a reference to search within an image for a matching object, disregarding other, more general options. The researchers provide the example of the tool being used to search for a specific zebra in an image filled with zebras, guided solely by a sketch of one zebra eating. The AI tool considers visual cues such as posture and structure but bases its decisions primarily on the exact specifications provided by the user's sketch. This ability to teach machine learning tools to identify specific objects in a particular image and discard others is a breakthrough that could lead to significant improvements in cancer detection, say the researchers.

“The ability for AI to detect objects based on individual amateur sketches introduces a significant leap in harnessing human creativity in Computer Vision,” said Professor Yi-Zhe Song, who is leading this research at the University of Surrey's Institute for People-Centred AI. “It allows humans to interact with AI from a whole different perspective, no longer letting AI dictate the decisions, but asking it to behave exactly as instructed, keeping necessary human intervention.”

Related Links:
University of Surrey 


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.